Rxrx stock forecast.

Nov 30, 2023 · Stock analysis for Recursion Pharmaceuticals Inc (RXRX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sep 11, 2023 · Recursion Pharmaceuticals (RXRX 7.88%) is a biotech that's riding a hype wave unlike any other. By staking its fame and investors' cash on its artificial intelligence (AI) platform for drug ... Dec 1, 2023 · Earnings for Recursion Pharmaceuticals are expected to decrease in the coming year, from ($1.67) to ($1.91) per share. Recursion Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 26th, 2024 based off prior year's report dates. Read More. The consensus price target of analysts on Wall Street is $16.00, which implies an increase of 65.31% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $35.00 respectively. As a result, RXRX is trading at a discount of -530.63% off the target high and -62.16% off the low.Find the latest ARK Genomic Revolution ETF (ARKG) stock quote, history, news and other vital information to help you with your stock trading and investing.

Recursion Pharmaceuticals Inc. research and ratings by Barron's. View RXRX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.4.31%. €8.59M. RXRX | Complete Recursion Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Forecast for Fri 01 Sep 2023 price 7.05 RECURSION PHARMACEUTICALS INC stock price forecast for further price development up to 32.48% (time horizon: 1 day) and price target of 7.01 USD. Short-term (time horizon: 2 weeks) RECURSION PHARMACEUTICALS INC share price prediction for 2023-09-01 with daily closed price …But the potential upside remains huge. Our roundtable group dug into her holdings and found three stocks that we particularly like. Here's why we're bullish on 10x Genomics ( TXG 2.96%), Beam ...

Before the stock market opened, RXRX stock had catapulted more than 130%. Nvidia stock rose 3.5% to 439.02. Recursion has a searchable data set spanning biology and chemistry. The company says its ...In particular, both Ginkgo Bioworks (NYSE: DNA) and Recursion Pharmaceuticals (NASDAQ: RXRX) are already implementing AI, and in the long term, it could be a crucial factor in their success.8 нояб. 2023 г. ... RXRX Stock Recursion Pharmaceuticals top stocks to buy in August ... Unity Stock New CEO Prioritizes Investors Over Stock Price. Jose Najarro ...

Nov 7, 2023 · Analyst projections state that RXRX is forecast to be at a low of $9.00 and a high of $35.00. In order for the stock price to hit the forecast high, the stock would need to plunge -532.91% from its current level, while the stock would need to crash -62.75% from its current level to reach the projected low.

Recursion Pharmaceuticals Inc. 7.06. Delayed Data. As of Nov 17. +0.39 / +5.85%. Today’s Change. 4.54. Today ||| 52-Week Range. 16.75.

Jul 12, 2023 · For RXRX stock, which has suffered sharp losses against a long-term framework, AI may put the underlying company on the right track again. Still, investors need to be aware of separating the ... The US$14.13 analyst price target for RXRX is 3.5% less than our ... we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and discounting ...Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...As of 03:16PM EST. Market open. See Recursion Pharmaceuticals, Inc. (RXRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The above table shows the analyst RXRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$7.39beststocks.com

Beam Therapeutics Inc. (BEAM) The first Wood-backed stock we’ll look at is Beam Therapeutics, a pioneer in the application of base editing. This is a potentially new class of precision genetic ...(See RXRX stock forecast) Roblox Corporation ( RBLX ) The AI trend has driven 2023’s bullish market sentiment, but one previously anticipated trend has failed to materialize.Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's forecasts.The consensus statutory numbers ...The latest price target for Recursion Pharmaceuticals ( NASDAQ: RXRX) was reported by JP Morgan on Monday, November 13, 2023. The analyst firm set a price target for 10.00 expecting RXRX to rise ...According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Current. -$0.35. 1 Month Ago. -$0.35. 3 Months Ago. -$0.32. Recursion Pharmaceuticals Inc. analyst estimates, including RXRX earnings per share estimates and analyst recommendations.

Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for RXRX stock stock is $15.33, which predicts an …Dec 1, 2023 · Company Summary. Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data ...

Should You Buy or Sell Recursion Pharmaceuticals Stock? Get The Latest RXRX Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Recursion Pharmaceuticals Stock Prediction. BSX. 6330 сент. 2023 г. ... NASDAQ: RXRX. Recursion Pharmaceuticals. Recursion Pharmaceuticals Stock Quote. Market Cap. $2B. Today's Change. (0.43%) $0.03. Current Price.The company's shares are currently changing hands for $7.07 apiece, but the consensus one-year target for the stock is $15.57, which implies that it could rise by about 120% over the next 12 months.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.View live Recursion Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, RXRX financials and market news.What is Recursion Pharmaceuticals, Inc. (RXRX) stock EPS forecast? Recursion Pharmaceuticals, Inc. missed analysts’ expectations during the last earnings period by 13.16% . Recursion Pharmaceuticals, Inc. reported earnings of -$ 0.43 per share on Nov 9, 2023, while the forecasted EPS was -$ 0.38.Forecast . Price target. 15.71 0.00 0.00%. The 7 analysts offering 1 year price forecasts for RXRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 7 analysts giving stock ratings to RXRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreFind the latest Earnings Report Date for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at ... Read our earnings report guide before you consider the forecast information when making ...As of Monday, July 24, Recursion Pharmaceuticals Inc’s RXRX share price has dipped by 7.69%, which has investors questioning if this is right time to buy. Premium ... Whether you decide it’s a good time to buy or sell Recursion Pharmaceuticals Inc’s stock based on its stock price forecast is ultimately up to you.

The latest price target for Recursion Pharmaceuticals ( NASDAQ: RXRX) was reported by JP Morgan on Monday, November 13, 2023. The analyst firm set a price target for 10.00 expecting RXRX to rise ...

Find the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock quote, history, news and other vital information to help you with your stock trading and investing. The company raised guidance for annual organic revenue growth from an earlier forecast of between 5% and 7% to between 6% and 8%. It also raised annual adjusted EPS to be between $3.70 and $3.85 ...Recursion Pharma (NASDAQ: RXRX) made waves this week. ... AMZN Stock Forecast: Predicting Amazon's Performance in 2023 and Beyond Stocks to Buy Nov 21, 2023 3 Stocks to Buy With Your Holiday Bonus ...Nov 24, 2023 · The Recursion Pharmaceuticals, Inc. stock price gained 1.18% on the last trading day (Friday, 24th Nov 2023), rising from $6.78 to $6.86. During the last trading day the stock fluctuated 5.06% from a day low at $6.71 to a day high of $7.05. The price has risen in 7 of the last 10 days and is up by 31.17% over the past 2 weeks. The US$14.13 analyst price target for RXRX is 3.5% ... we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and discounting them back to today's ...Oct 11, 2023 · On the bottom line, Recursion's net loss per share of $0.38 remained flat compared to the prior-year quarter. The company ended the period with $405.9 million in cash and equivalents, which does ... 5 equities research analysts have issued 12 month price objectives for Amneal Pharmaceuticals' stock. Their AMRX share price targets range from $3.00 to $7.00. On average, they expect the company's share price to reach $4.80 in the next twelve months. This suggests a possible upside of 9.8% from the stock's current price.Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought. Which Recursion Pharmaceuticals insiders have been selling company stock? The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($2,846,394.44), Christopher Gibson ($14,439,192.59), …

Jul 24, 2023 · As of July 24, 2023, 4:00 PM CST, Recursion Pharmaceuticals Inc’s stock price was $14.28. Recursion Pharmaceuticals Inc is down 7.69% from its previous closing price of $15.47. During the last market session, Recursion Pharmaceuticals Inc’s stock traded between $14.36 and $16.09. Analyst Forecast According to 6 analysts, the average rating for RXRX stock is "Buy." The 12-month stock price forecast is $15.33, which is an increase of 107.44% from the latest price.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ... Instagram:https://instagram. vanguard total stock etfpenny stocks to watch todayaapl stock predictionsg.t.e. stock price Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...The 23andMe Holding Co. stock forecast for tomorrow is $ 0.786773, which would represent a -1.46% loss compared to the current price. In the next week, the price of ME is expected to decrease by -7.39% and hit $ 0.739421. As far as the long-term 23andMe Holding Co. stock forecast is concerned, here’s what our predictions are currently suggesting. jane elferslincoln bicentennial penny Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.The company, currently valued at $1.60B, closed the last trade at $7.39 per share which meant it gained $0.54 on the day or 7.88% during that session. The RXRX stock price is -126.66% off its 52-week high price of $16.75 and 38.57% above the 52-week low of $4.54. If we look at the company’s 10-day average daily trading volume, we find that it ... harborway insurance reddit Next reporting date: February 14, 2024: EPS forecast (this quarter) $0.95: Annual revenue (last year) $2.2B: Annual profit (last year) $42.8M: Net profit marginZillow is worth $8.3 billion right now, so if it reaches its 2025 sales estimate and continues to grow thereafter, it should breeze past a $10 billion valuation by 2030. 2. Duolingo: Potential ...